Now showing items 1-3 of 3

    • Aretxabala, Xabier de; Roa, Iván; Berríos Flores, Marcela Paz; Hepp, Juan; Gallardo, Jorge; Córdova, Andrés; Roa, Juan Carlos; León, Jorge; Maluenda, Fernando (WILEY-LISS, DIV JOHN WILEY & SONS INC, 2006-06-15)
      Gallbladder cancer (GC) is considered a rare disease associated with a poor prognosis. Unfortunately, the low number of cases makes the performance of trials addressing the role of adjuvant, neoadjuvant, and/or palliative ...
    • Müller, Bettina; Arroyo, Gerardo; Gallardo, Jorge; Villanueva Olivares, Luis; González, Pablo; Baeza, Ramón; Aretxabala, Xabier de; Maluenda, Fernando; Acevedo, Alejandro; Chuecas, Fernando; Díaz Jeraldo, Juan; García S., César; Reyes, José Miguel; Navarrete, Claudio (Sociedad Médica de Santiago, 2011-02)
    • Córdova Delgado, Miguel Angel; Pinto, Mauricio P.; Regonesi, Carlos; Cereceda, Luis; Reyes, José Miguel; Itriago, Laura; Majlis, Alejandro; Rodríguez, Pablo; Fassler, André; Mahave, Mauricio; León, María Elisa; Gallardo, Jorge; Rodríguez Z., María Paz; Berkovits, Alejandro; Manque, Patricio; Ríos, Juvenal A.; García Bloj, Benjamín; Garrido, Marcelo (MDPI, 2022)
      Major advances in sequencing technologies and targeted therapies have accelerated the incorporation of oncology into the era of precision medicine and "biomarker-driven" treatments. However, the impact of this approach on ...